Miridesap
| CAS No. | 224624-80-0 | Cat. No. | BCP17580 |
| Name | Miridesap | ||
| Synonyms | Ro-638695； Ro 638695； Ro638695；GSK-2315698； GSK 2315698； GSK2315698；CPHPC；CPOHPC; | ||
| Formula | C16H24N2O6 | M. Wt | 340.37 |
| Description | Miridesap (also known as Ro-638695, GSK-2315698, and CPHPC) is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies. Since Miridesap removes SAP from the blood, it also removes SAP from the cerebrospinal fluid (CSF). | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.